Research


Study: Gemcitabine helps prevent recurrence of low-grade bladder cancer

May 16, 2018
 

A multi-institution clinical trial involving researchers from UT Health San Antonio shows significantly lower recurrence of bladder cancer in patients who received the chemotherapy drug gemcitabine.

Read more


Audio spots focus on the how and why of what we do at UT Health San Antonio

May 7, 2018
 

To help increase awareness and preference for our organization, UT Health San Antonio has launched a highly visible ad campaign.

Read more


Trend shows later onset of dementia, fewer years of the disease

April 24, 2018
 

Findings could be related to reduced stroke risk.

Read more


Four trainees to present at American Association of Immunologists meeting

April 23, 2018
 

Four trainees in the  Infection, Inflammation and Immunity (III) discipline of the Integrated Biomedical Sciences Ph.D. program and Department of Microbiology, Immunology and Molecular Genetics will make podium presentations in the upcoming American Association of Immunologists Annual Meeting in Austin, May 4-8. Read their stories

Read more

FDA panel recommends CBD medication for epilepsy

April 20, 2018
 

se E. Cavazos, M.D., Ph.D., professor of neurology and physiology at UT Health San Antonio and assistant dean of the institution’s M.D./Ph.D. program, reviewed clinical studies of the drug, which would be sold under the brand name Epidiolex.

Read more

Annual dental symposium features posters, talks, new mentor award

April 18, 2018
 

The symposium celebrates accomplishments in all areas of research, including education, public health, clinical sciences and basic sciences.

Read more